Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

RTTNews | Pred 1042 dňami
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.

EGFR inhibitors are critical therapeutic agents for the treatment of non-small cell lung cancer (NSCLC), pancreatic cancer, colorectal cancer, squamous-cell carcinoma of the head and neck, and breast cancer.

The company said this trial brings us one step closer to a new treatment option for underserved cancer patients as there is no specific treatment currently approved for the treatment of skin toxicities associated with EGFRi therapies.

The company added it will advance HT-001 into the clinical phase as it is a key treatment in the onco-dermatology space and anticipates beginning the Phase 2a trial in the first quarter of 2023.

read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | Pred 786 dňami
Asian Markets Track Wall Street Higher

Asian Markets Track Wall Street Higher

Asian markets are trading mostly higher on Thursday, following the broadly positive cues from Wall Street overnight, as some traders looked to pick up stocks at reduced levels following the recent sell-off. Traders also react to upbeat private US economic data and growing expectations that the US Supreme Court may reject the Trump administration's aggressive trade policy.
RTTNews | Pred 1 h 17 min
Japanese Market Sharply Higher

Japanese Market Sharply Higher

The Japanese market is sharply higher on Thursday, snapping a five-session losing streak, following the broadly positive cues from Wall Street overnight. The Nikkei 225 is moving up almost 2 percent to above the 50,900 level, with gains across most sectors led by index heavyweights, exporters and financial stocks.
RTTNews | Pred 1 h 41 min
Thai Stock Market May Reclaim 1,300-Point Plateau

Thai Stock Market May Reclaim 1,300-Point Plateau

The Thai stock market has moved lower in five straight sessions, slumping more than 15 points or 1.2 percent along the way. The Stock Exchange of Thailand now sits just shy of the 1,300-point plateau although it's expected to open to the upside on Thursday.
RTTNews | Pred 2 h 13 min
Additional Support Anticipated For Indonesia Shares

Additional Support Anticipated For Indonesia Shares

The Indonesia stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day winning streak in which it had picked up almost 100 points or 1.2 percent. The Jakarta Composite Index now sits just beneath the 8,320-point plateau and it may add to its winnings on Thursday.
RTTNews | Pred 2 h 43 min